Dendritic cell-glioma fusion activates T lymphocytes by elevating cytotoxic efficiency as an antitumor vaccine

BACKGROUND: Hybrid cells produced by fusions of tumor and dendritic cells (DC) have demonstrated remarkable efficacy for priming the anti-tumor immune response. In the current study, we examined the antitumor activity of cytotoxic T lymphocytes (CTLs) primed in response to a tumor vaccine comprising...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Fuming, Dou, Changwu, Qi, Songtao, Chen, Bo, Zhao, Liqun, Wang, Xiaojuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Society of Experimental and Clinical Immunology 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439993/
https://www.ncbi.nlm.nih.gov/pubmed/26155134
http://dx.doi.org/10.5114/ceji.2014.45935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439993/
https://www.ncbi.nlm.nih.gov/pubmed/26155134
http://dx.doi.org/10.5114/ceji.2014.45935

Ejemplares similares